2023
DOI: 10.3389/fonc.2023.1260374
|View full text |Cite
|
Sign up to set email alerts
|

AI/ML advances in non-small cell lung cancer biomarker discovery

Minal Çalışkan,
Koichi Tazaki

Abstract: Lung cancer is the leading cause of cancer deaths among both men and women, representing approximately 25% of cancer fatalities each year. The treatment landscape for non-small cell lung cancer (NSCLC) is rapidly evolving due to the progress made in biomarker-driven targeted therapies. While advancements in targeted treatments have improved survival rates for NSCLC patients with actionable biomarkers, long-term survival remains low, with an overall 5-year relative survival rate below 20%. Artificial intelligen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2025
2025

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
references
References 224 publications
(281 reference statements)
0
0
0
Order By: Relevance